Dr Artavanis-Tsakonas is the founding Director of The Department of Genetics and Developmental Biology at the Curie Institute. He maintains a small experimental presence at the Department supported by the Collège de France, which is headed by Dr. Silvia Fre exploring cell lineages and tumourigenesis in the mouse intestine. There is a close collaboration with the Dr. Daniel Louvard group, particularly with Dr. Sylvie Robine at the same Institute in Paris.
Collège de France
Collège de France is a public Institution established in 1501 devoted to the open teaching of specialized topics. Fifty Professors offer yearly lectures and seminars on Natural Sciences, Physical Sciences and Humanities that can be attended by everyone.
The Exelixis Collection was generated by Exelixis Inc. and donated to us to be distributed to the academic research community. This collection of ~16,000 transgenic fly stocks contains mutations in ~52% of the genes in the Drosophila genome.
Notch signalling involvement in the development of the mammary gland and the intestine: Proliferation, Tumourigenesis and Stem Cell biology
Joan Brugge, Harvard Medical School
Hippokratis Kiaris, Athens University
Daniel Louvard, and Sylvie Robine, Curie Institute Paris
Jeffery Greve, Exelixis, Inc.
Ramesh Shivdasani, Harvard Medical School & Dana-Farver Cancer Institute
The protein complex map of Drosophila, Proteomic studies
Susan Celniker, UC Berkeley
Steve Gygi, Harvard Medical School
K. VijayRaghavan, TIFR Bangalore, India
Manolis Kellis, Broad Institute of MIT and Harvard
Live cell imaging analysis of Notch pathway element trafficking
Tomas Kirchhausen, Harvard Medical School
Robert Fleming, Trinity College
Alexey Veraksa, U Mass Boston
Notch signalling in vascular biology and the CADASIL syndrome
Angeliki Louvi, Yale University
Michael Moskowitz, Massachusetts General Hospital
Patricia D’Amore, Schepens Eye Research Institute, Harvard Medical School
Electron Microscopy based structural studies on the Notch receptor and its ligands
Tom Walz, Harvard Medical School
Modelling Spinal Muscular Atrophy : A genetic approach to identify therapeutic targets
Anne Hart, Brown University
Lee Rubin, Harvard Stem Cell Institute
David Van Vactor, Harvard Medical School
Dan Curtis, Novartis Institutes for Biomedical Resarch, Boston